nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—Ill-defined disorder—Alendronate—Paget's disease of bone	0.0023	0.0023	CcSEcCtD
Telmisartan—Anaemia—Alendronate—Paget's disease of bone	0.00229	0.00229	CcSEcCtD
Telmisartan—Rhinitis—Risedronate—Paget's disease of bone	0.00229	0.00229	CcSEcCtD
Telmisartan—Pollakiuria—Zoledronate—Paget's disease of bone	0.00229	0.00229	CcSEcCtD
Telmisartan—Sinusitis—Pamidronate—Paget's disease of bone	0.00227	0.00227	CcSEcCtD
Telmisartan—Pharyngitis—Risedronate—Paget's disease of bone	0.00227	0.00227	CcSEcCtD
Telmisartan—Angioedema—Alendronate—Paget's disease of bone	0.00227	0.00227	CcSEcCtD
Telmisartan—Urinary tract disorder—Risedronate—Paget's disease of bone	0.00226	0.00226	CcSEcCtD
Telmisartan—Oedema peripheral—Risedronate—Paget's disease of bone	0.00225	0.00225	CcSEcCtD
Telmisartan—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00225	0.00225	CcSEcCtD
Telmisartan—Urethral disorder—Risedronate—Paget's disease of bone	0.00224	0.00224	CcSEcCtD
Telmisartan—Malaise—Alendronate—Paget's disease of bone	0.00224	0.00224	CcSEcCtD
Telmisartan—Vertigo—Alendronate—Paget's disease of bone	0.00223	0.00223	CcSEcCtD
Telmisartan—Infestation—Zoledronate—Paget's disease of bone	0.00221	0.00221	CcSEcCtD
Telmisartan—Infestation NOS—Zoledronate—Paget's disease of bone	0.00221	0.00221	CcSEcCtD
Telmisartan—Depression—Zoledronate—Paget's disease of bone	0.00221	0.00221	CcSEcCtD
Telmisartan—Rhinitis—Pamidronate—Paget's disease of bone	0.00218	0.00218	CcSEcCtD
Telmisartan—Renal failure—Zoledronate—Paget's disease of bone	0.00217	0.00217	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00216	0.00216	CcSEcCtD
Telmisartan—Conjunctivitis—Zoledronate—Paget's disease of bone	0.00215	0.00215	CcSEcCtD
Telmisartan—Urinary tract infection—Zoledronate—Paget's disease of bone	0.00215	0.00215	CcSEcCtD
Telmisartan—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00215	0.00215	CcSEcCtD
Telmisartan—Eye disorder—Risedronate—Paget's disease of bone	0.00214	0.00214	CcSEcCtD
Telmisartan—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.00214	0.00214	CcSEcCtD
Telmisartan—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00213	0.00213	CcSEcCtD
Telmisartan—Tinnitus—Risedronate—Paget's disease of bone	0.00213	0.00213	CcSEcCtD
Telmisartan—Urethral disorder—Pamidronate—Paget's disease of bone	0.00213	0.00213	CcSEcCtD
Telmisartan—Cardiac disorder—Risedronate—Paget's disease of bone	0.00212	0.00212	CcSEcCtD
Telmisartan—Chest pain—Alendronate—Paget's disease of bone	0.00211	0.00211	CcSEcCtD
Telmisartan—Myalgia—Alendronate—Paget's disease of bone	0.00211	0.00211	CcSEcCtD
Telmisartan—Haematuria—Zoledronate—Paget's disease of bone	0.00211	0.00211	CcSEcCtD
Telmisartan—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00209	0.00209	CcSEcCtD
Telmisartan—Discomfort—Alendronate—Paget's disease of bone	0.00209	0.00209	CcSEcCtD
Telmisartan—Angiopathy—Risedronate—Paget's disease of bone	0.00207	0.00207	CcSEcCtD
Telmisartan—Immune system disorder—Risedronate—Paget's disease of bone	0.00207	0.00207	CcSEcCtD
Telmisartan—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00206	0.00206	CcSEcCtD
Telmisartan—Arrhythmia—Risedronate—Paget's disease of bone	0.00204	0.00204	CcSEcCtD
Telmisartan—Constipation—Etidronic acid—Paget's disease of bone	0.00203	0.00203	CcSEcCtD
Telmisartan—Eye disorder—Pamidronate—Paget's disease of bone	0.00203	0.00203	CcSEcCtD
Telmisartan—Bradycardia—Zoledronate—Paget's disease of bone	0.00202	0.00202	CcSEcCtD
Telmisartan—Flushing—Pamidronate—Paget's disease of bone	0.00202	0.00202	CcSEcCtD
Telmisartan—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00202	0.00202	CcSEcCtD
Telmisartan—Infection—Alendronate—Paget's disease of bone	0.00201	0.00201	CcSEcCtD
Telmisartan—Mental disorder—Risedronate—Paget's disease of bone	0.002	0.002	CcSEcCtD
Telmisartan—Malnutrition—Risedronate—Paget's disease of bone	0.00199	0.00199	CcSEcCtD
Telmisartan—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.00198	0.00198	CcSEcCtD
Telmisartan—Angiopathy—Pamidronate—Paget's disease of bone	0.00197	0.00197	CcSEcCtD
Telmisartan—Immune system disorder—Pamidronate—Paget's disease of bone	0.00196	0.00196	CcSEcCtD
Telmisartan—Flatulence—Risedronate—Paget's disease of bone	0.00196	0.00196	CcSEcCtD
Telmisartan—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00196	0.00196	CcSEcCtD
Telmisartan—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00196	0.00196	CcSEcCtD
Telmisartan—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00196	0.00196	CcSEcCtD
Telmisartan—Oedema peripheral—Zoledronate—Paget's disease of bone	0.00196	0.00196	CcSEcCtD
Telmisartan—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.00195	0.00195	CcSEcCtD
Telmisartan—Chills—Pamidronate—Paget's disease of bone	0.00195	0.00195	CcSEcCtD
Telmisartan—Urethral disorder—Zoledronate—Paget's disease of bone	0.00195	0.00195	CcSEcCtD
Telmisartan—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00194	0.00194	CcSEcCtD
Telmisartan—Back pain—Risedronate—Paget's disease of bone	0.00193	0.00193	CcSEcCtD
Telmisartan—Muscle spasms—Risedronate—Paget's disease of bone	0.00191	0.00191	CcSEcCtD
Telmisartan—Malnutrition—Pamidronate—Paget's disease of bone	0.00189	0.00189	CcSEcCtD
Telmisartan—Erythema—Pamidronate—Paget's disease of bone	0.00189	0.00189	CcSEcCtD
Telmisartan—Urticaria—Etidronic acid—Paget's disease of bone	0.00189	0.00189	CcSEcCtD
Telmisartan—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00188	0.00188	CcSEcCtD
Telmisartan—Tension—Pamidronate—Paget's disease of bone	0.00186	0.00186	CcSEcCtD
Telmisartan—Eye disorder—Zoledronate—Paget's disease of bone	0.00186	0.00186	CcSEcCtD
Telmisartan—Dysgeusia—Pamidronate—Paget's disease of bone	0.00185	0.00185	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00184	0.00184	CcSEcCtD
Telmisartan—Cardiac disorder—Zoledronate—Paget's disease of bone	0.00184	0.00184	CcSEcCtD
Telmisartan—Flushing—Zoledronate—Paget's disease of bone	0.00184	0.00184	CcSEcCtD
Telmisartan—Anaemia—Risedronate—Paget's disease of bone	0.00184	0.00184	CcSEcCtD
Telmisartan—Nervousness—Pamidronate—Paget's disease of bone	0.00184	0.00184	CcSEcCtD
Telmisartan—Back pain—Pamidronate—Paget's disease of bone	0.00183	0.00183	CcSEcCtD
Telmisartan—Muscle spasms—Pamidronate—Paget's disease of bone	0.00182	0.00182	CcSEcCtD
Telmisartan—Angioedema—Risedronate—Paget's disease of bone	0.00182	0.00182	CcSEcCtD
Telmisartan—Angiopathy—Zoledronate—Paget's disease of bone	0.0018	0.0018	CcSEcCtD
Telmisartan—Immune system disorder—Zoledronate—Paget's disease of bone	0.00179	0.00179	CcSEcCtD
Telmisartan—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.00179	0.00179	CcSEcCtD
Telmisartan—Vertigo—Risedronate—Paget's disease of bone	0.00179	0.00179	CcSEcCtD
Telmisartan—Syncope—Risedronate—Paget's disease of bone	0.00178	0.00178	CcSEcCtD
Telmisartan—Dyspepsia—Alendronate—Paget's disease of bone	0.00178	0.00178	CcSEcCtD
Telmisartan—Chills—Zoledronate—Paget's disease of bone	0.00178	0.00178	CcSEcCtD
Telmisartan—Arrhythmia—Zoledronate—Paget's disease of bone	0.00177	0.00177	CcSEcCtD
Telmisartan—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.00176	0.00176	CcSEcCtD
Telmisartan—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00175	0.00175	CcSEcCtD
Telmisartan—Loss of consciousness—Risedronate—Paget's disease of bone	0.00175	0.00175	CcSEcCtD
Telmisartan—Anaemia—Pamidronate—Paget's disease of bone	0.00175	0.00175	CcSEcCtD
Telmisartan—Mental disorder—Zoledronate—Paget's disease of bone	0.00174	0.00174	CcSEcCtD
Telmisartan—Cough—Risedronate—Paget's disease of bone	0.00174	0.00174	CcSEcCtD
Telmisartan—Constipation—Alendronate—Paget's disease of bone	0.00173	0.00173	CcSEcCtD
Telmisartan—Pain—Alendronate—Paget's disease of bone	0.00173	0.00173	CcSEcCtD
Telmisartan—Angioedema—Pamidronate—Paget's disease of bone	0.00173	0.00173	CcSEcCtD
Telmisartan—Malnutrition—Zoledronate—Paget's disease of bone	0.00173	0.00173	CcSEcCtD
Telmisartan—Erythema—Zoledronate—Paget's disease of bone	0.00173	0.00173	CcSEcCtD
Telmisartan—Hypertension—Risedronate—Paget's disease of bone	0.00172	0.00172	CcSEcCtD
Telmisartan—Malaise—Pamidronate—Paget's disease of bone	0.00171	0.00171	CcSEcCtD
Telmisartan—Syncope—Pamidronate—Paget's disease of bone	0.0017	0.0017	CcSEcCtD
Telmisartan—Arthralgia—Risedronate—Paget's disease of bone	0.00169	0.00169	CcSEcCtD
Telmisartan—Chest pain—Risedronate—Paget's disease of bone	0.00169	0.00169	CcSEcCtD
Telmisartan—Myalgia—Risedronate—Paget's disease of bone	0.00169	0.00169	CcSEcCtD
Telmisartan—Dysgeusia—Zoledronate—Paget's disease of bone	0.00169	0.00169	CcSEcCtD
Telmisartan—Anxiety—Risedronate—Paget's disease of bone	0.00169	0.00169	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00168	0.00168	CcSEcCtD
Telmisartan—Pruritus—Etidronic acid—Paget's disease of bone	0.00168	0.00168	CcSEcCtD
Telmisartan—Back pain—Zoledronate—Paget's disease of bone	0.00167	0.00167	CcSEcCtD
Telmisartan—Feeling abnormal—Alendronate—Paget's disease of bone	0.00167	0.00167	CcSEcCtD
Telmisartan—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00166	0.00166	CcSEcCtD
Telmisartan—Muscle spasms—Zoledronate—Paget's disease of bone	0.00166	0.00166	CcSEcCtD
Telmisartan—Dry mouth—Risedronate—Paget's disease of bone	0.00166	0.00166	CcSEcCtD
Telmisartan—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00166	0.00166	CcSEcCtD
Telmisartan—Cough—Pamidronate—Paget's disease of bone	0.00165	0.00165	CcSEcCtD
Telmisartan—Hypertension—Pamidronate—Paget's disease of bone	0.00163	0.00163	CcSEcCtD
Telmisartan—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00163	0.00163	CcSEcCtD
Telmisartan—Infection—Risedronate—Paget's disease of bone	0.00161	0.00161	CcSEcCtD
Telmisartan—Arthralgia—Pamidronate—Paget's disease of bone	0.00161	0.00161	CcSEcCtD
Telmisartan—Myalgia—Pamidronate—Paget's disease of bone	0.00161	0.00161	CcSEcCtD
Telmisartan—Urticaria—Alendronate—Paget's disease of bone	0.00161	0.00161	CcSEcCtD
Telmisartan—Anxiety—Pamidronate—Paget's disease of bone	0.00161	0.00161	CcSEcCtD
Telmisartan—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.0016	0.0016	CcSEcCtD
Telmisartan—Body temperature increased—Alendronate—Paget's disease of bone	0.0016	0.0016	CcSEcCtD
Telmisartan—Abdominal pain—Alendronate—Paget's disease of bone	0.0016	0.0016	CcSEcCtD
Telmisartan—Shock—Risedronate—Paget's disease of bone	0.0016	0.0016	CcSEcCtD
Telmisartan—Anaemia—Zoledronate—Paget's disease of bone	0.0016	0.0016	CcSEcCtD
Telmisartan—Nervous system disorder—Risedronate—Paget's disease of bone	0.00159	0.00159	CcSEcCtD
Telmisartan—Discomfort—Pamidronate—Paget's disease of bone	0.00159	0.00159	CcSEcCtD
Telmisartan—Angioedema—Zoledronate—Paget's disease of bone	0.00158	0.00158	CcSEcCtD
Telmisartan—Skin disorder—Risedronate—Paget's disease of bone	0.00158	0.00158	CcSEcCtD
Telmisartan—Malaise—Zoledronate—Paget's disease of bone	0.00156	0.00156	CcSEcCtD
Telmisartan—Vertigo—Zoledronate—Paget's disease of bone	0.00155	0.00155	CcSEcCtD
Telmisartan—Syncope—Zoledronate—Paget's disease of bone	0.00155	0.00155	CcSEcCtD
Telmisartan—Oedema—Pamidronate—Paget's disease of bone	0.00154	0.00154	CcSEcCtD
Telmisartan—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00154	0.00154	CcSEcCtD
Telmisartan—Infection—Pamidronate—Paget's disease of bone	0.00153	0.00153	CcSEcCtD
Telmisartan—Palpitations—Zoledronate—Paget's disease of bone	0.00153	0.00153	CcSEcCtD
Telmisartan—Shock—Pamidronate—Paget's disease of bone	0.00152	0.00152	CcSEcCtD
Telmisartan—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00152	0.00152	CcSEcCtD
Telmisartan—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00151	0.00151	CcSEcCtD
Telmisartan—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00151	0.00151	CcSEcCtD
Telmisartan—Vomiting—Etidronic acid—Paget's disease of bone	0.00151	0.00151	CcSEcCtD
Telmisartan—Cough—Zoledronate—Paget's disease of bone	0.00151	0.00151	CcSEcCtD
Telmisartan—Tachycardia—Pamidronate—Paget's disease of bone	0.00151	0.00151	CcSEcCtD
Telmisartan—Rash—Etidronic acid—Paget's disease of bone	0.0015	0.0015	CcSEcCtD
Telmisartan—Dermatitis—Etidronic acid—Paget's disease of bone	0.0015	0.0015	CcSEcCtD
Telmisartan—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00149	0.00149	CcSEcCtD
Telmisartan—Hypertension—Zoledronate—Paget's disease of bone	0.00149	0.00149	CcSEcCtD
Telmisartan—Hypersensitivity—Alendronate—Paget's disease of bone	0.00149	0.00149	CcSEcCtD
Telmisartan—Headache—Etidronic acid—Paget's disease of bone	0.00149	0.00149	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00148	0.00148	CcSEcCtD
Telmisartan—Anorexia—Pamidronate—Paget's disease of bone	0.00147	0.00147	CcSEcCtD
Telmisartan—Chest pain—Zoledronate—Paget's disease of bone	0.00147	0.00147	CcSEcCtD
Telmisartan—Myalgia—Zoledronate—Paget's disease of bone	0.00147	0.00147	CcSEcCtD
Telmisartan—Arthralgia—Zoledronate—Paget's disease of bone	0.00147	0.00147	CcSEcCtD
Telmisartan—Insomnia—Risedronate—Paget's disease of bone	0.00147	0.00147	CcSEcCtD
Telmisartan—Anxiety—Zoledronate—Paget's disease of bone	0.00147	0.00147	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00146	0.00146	CcSEcCtD
Telmisartan—Paraesthesia—Risedronate—Paget's disease of bone	0.00146	0.00146	CcSEcCtD
Telmisartan—Discomfort—Zoledronate—Paget's disease of bone	0.00145	0.00145	CcSEcCtD
Telmisartan—Asthenia—Alendronate—Paget's disease of bone	0.00145	0.00145	CcSEcCtD
Telmisartan—Dyspnoea—Risedronate—Paget's disease of bone	0.00145	0.00145	CcSEcCtD
Telmisartan—Hypotension—Pamidronate—Paget's disease of bone	0.00144	0.00144	CcSEcCtD
Telmisartan—Dry mouth—Zoledronate—Paget's disease of bone	0.00144	0.00144	CcSEcCtD
Telmisartan—Pruritus—Alendronate—Paget's disease of bone	0.00143	0.00143	CcSEcCtD
Telmisartan—Dyspepsia—Risedronate—Paget's disease of bone	0.00143	0.00143	CcSEcCtD
Telmisartan—Nausea—Etidronic acid—Paget's disease of bone	0.00141	0.00141	CcSEcCtD
Telmisartan—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.00141	0.00141	CcSEcCtD
Telmisartan—Oedema—Zoledronate—Paget's disease of bone	0.00141	0.00141	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00141	0.00141	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.0014	0.0014	CcSEcCtD
Telmisartan—Infection—Zoledronate—Paget's disease of bone	0.0014	0.0014	CcSEcCtD
Telmisartan—Fatigue—Risedronate—Paget's disease of bone	0.0014	0.0014	CcSEcCtD
Telmisartan—Insomnia—Pamidronate—Paget's disease of bone	0.0014	0.0014	CcSEcCtD
Telmisartan—Pain—Risedronate—Paget's disease of bone	0.00139	0.00139	CcSEcCtD
Telmisartan—Constipation—Risedronate—Paget's disease of bone	0.00139	0.00139	CcSEcCtD
Telmisartan—Shock—Zoledronate—Paget's disease of bone	0.00139	0.00139	CcSEcCtD
Telmisartan—Paraesthesia—Pamidronate—Paget's disease of bone	0.00139	0.00139	CcSEcCtD
Telmisartan—Diarrhoea—Alendronate—Paget's disease of bone	0.00139	0.00139	CcSEcCtD
Telmisartan—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00138	0.00138	CcSEcCtD
Telmisartan—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00138	0.00138	CcSEcCtD
Telmisartan—Dyspnoea—Pamidronate—Paget's disease of bone	0.00138	0.00138	CcSEcCtD
Telmisartan—Tachycardia—Zoledronate—Paget's disease of bone	0.00138	0.00138	CcSEcCtD
Telmisartan—Somnolence—Pamidronate—Paget's disease of bone	0.00137	0.00137	CcSEcCtD
Telmisartan—Skin disorder—Zoledronate—Paget's disease of bone	0.00137	0.00137	CcSEcCtD
Telmisartan—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.00136	0.00136	CcSEcCtD
Telmisartan—Dyspepsia—Pamidronate—Paget's disease of bone	0.00136	0.00136	CcSEcCtD
Telmisartan—Anorexia—Zoledronate—Paget's disease of bone	0.00134	0.00134	CcSEcCtD
Telmisartan—Decreased appetite—Pamidronate—Paget's disease of bone	0.00134	0.00134	CcSEcCtD
Telmisartan—Dizziness—Alendronate—Paget's disease of bone	0.00134	0.00134	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00133	0.00133	CcSEcCtD
Telmisartan—Fatigue—Pamidronate—Paget's disease of bone	0.00133	0.00133	CcSEcCtD
Telmisartan—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00133	0.00133	CcSEcCtD
Telmisartan—Constipation—Pamidronate—Paget's disease of bone	0.00132	0.00132	CcSEcCtD
Telmisartan—Pain—Pamidronate—Paget's disease of bone	0.00132	0.00132	CcSEcCtD
Telmisartan—Hypotension—Zoledronate—Paget's disease of bone	0.00132	0.00132	CcSEcCtD
Telmisartan—Urticaria—Risedronate—Paget's disease of bone	0.00129	0.00129	CcSEcCtD
Telmisartan—Vomiting—Alendronate—Paget's disease of bone	0.00129	0.00129	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00129	0.00129	CcSEcCtD
Telmisartan—Abdominal pain—Risedronate—Paget's disease of bone	0.00128	0.00128	CcSEcCtD
Telmisartan—Body temperature increased—Risedronate—Paget's disease of bone	0.00128	0.00128	CcSEcCtD
Telmisartan—Rash—Alendronate—Paget's disease of bone	0.00128	0.00128	CcSEcCtD
Telmisartan—Insomnia—Zoledronate—Paget's disease of bone	0.00128	0.00128	CcSEcCtD
Telmisartan—Dermatitis—Alendronate—Paget's disease of bone	0.00128	0.00128	CcSEcCtD
Telmisartan—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00127	0.00127	CcSEcCtD
Telmisartan—Headache—Alendronate—Paget's disease of bone	0.00127	0.00127	CcSEcCtD
Telmisartan—Paraesthesia—Zoledronate—Paget's disease of bone	0.00127	0.00127	CcSEcCtD
Telmisartan—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00126	0.00126	CcSEcCtD
Telmisartan—Dyspnoea—Zoledronate—Paget's disease of bone	0.00126	0.00126	CcSEcCtD
Telmisartan—Somnolence—Zoledronate—Paget's disease of bone	0.00125	0.00125	CcSEcCtD
Telmisartan—Dyspepsia—Zoledronate—Paget's disease of bone	0.00124	0.00124	CcSEcCtD
Telmisartan—Decreased appetite—Zoledronate—Paget's disease of bone	0.00123	0.00123	CcSEcCtD
Telmisartan—Abdominal pain—Pamidronate—Paget's disease of bone	0.00122	0.00122	CcSEcCtD
Telmisartan—Body temperature increased—Pamidronate—Paget's disease of bone	0.00122	0.00122	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00122	0.00122	CcSEcCtD
Telmisartan—Fatigue—Zoledronate—Paget's disease of bone	0.00122	0.00122	CcSEcCtD
Telmisartan—Constipation—Zoledronate—Paget's disease of bone	0.00121	0.00121	CcSEcCtD
Telmisartan—Pain—Zoledronate—Paget's disease of bone	0.00121	0.00121	CcSEcCtD
Telmisartan—Nausea—Alendronate—Paget's disease of bone	0.0012	0.0012	CcSEcCtD
Telmisartan—Hypersensitivity—Risedronate—Paget's disease of bone	0.0012	0.0012	CcSEcCtD
Telmisartan—Asthenia—Risedronate—Paget's disease of bone	0.00117	0.00117	CcSEcCtD
Telmisartan—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00116	0.00116	CcSEcCtD
Telmisartan—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00115	0.00115	CcSEcCtD
Telmisartan—Pruritus—Risedronate—Paget's disease of bone	0.00115	0.00115	CcSEcCtD
Telmisartan—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00114	0.00114	CcSEcCtD
Telmisartan—Urticaria—Zoledronate—Paget's disease of bone	0.00112	0.00112	CcSEcCtD
Telmisartan—Abdominal pain—Zoledronate—Paget's disease of bone	0.00112	0.00112	CcSEcCtD
Telmisartan—Body temperature increased—Zoledronate—Paget's disease of bone	0.00112	0.00112	CcSEcCtD
Telmisartan—Diarrhoea—Risedronate—Paget's disease of bone	0.00111	0.00111	CcSEcCtD
Telmisartan—Asthenia—Pamidronate—Paget's disease of bone	0.00111	0.00111	CcSEcCtD
Telmisartan—Pruritus—Pamidronate—Paget's disease of bone	0.00109	0.00109	CcSEcCtD
Telmisartan—Dizziness—Risedronate—Paget's disease of bone	0.00107	0.00107	CcSEcCtD
Telmisartan—Diarrhoea—Pamidronate—Paget's disease of bone	0.00106	0.00106	CcSEcCtD
Telmisartan—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00104	0.00104	CcSEcCtD
Telmisartan—Vomiting—Risedronate—Paget's disease of bone	0.00103	0.00103	CcSEcCtD
Telmisartan—Rash—Risedronate—Paget's disease of bone	0.00102	0.00102	CcSEcCtD
Telmisartan—Dermatitis—Risedronate—Paget's disease of bone	0.00102	0.00102	CcSEcCtD
Telmisartan—Dizziness—Pamidronate—Paget's disease of bone	0.00102	0.00102	CcSEcCtD
Telmisartan—Headache—Risedronate—Paget's disease of bone	0.00102	0.00102	CcSEcCtD
Telmisartan—Asthenia—Zoledronate—Paget's disease of bone	0.00101	0.00101	CcSEcCtD
Telmisartan—Pruritus—Zoledronate—Paget's disease of bone	0.000998	0.000998	CcSEcCtD
Telmisartan—Vomiting—Pamidronate—Paget's disease of bone	0.000982	0.000982	CcSEcCtD
Telmisartan—Rash—Pamidronate—Paget's disease of bone	0.000974	0.000974	CcSEcCtD
Telmisartan—Dermatitis—Pamidronate—Paget's disease of bone	0.000973	0.000973	CcSEcCtD
Telmisartan—Headache—Pamidronate—Paget's disease of bone	0.000967	0.000967	CcSEcCtD
Telmisartan—Diarrhoea—Zoledronate—Paget's disease of bone	0.000965	0.000965	CcSEcCtD
Telmisartan—Nausea—Risedronate—Paget's disease of bone	0.000965	0.000965	CcSEcCtD
Telmisartan—Dizziness—Zoledronate—Paget's disease of bone	0.000933	0.000933	CcSEcCtD
Telmisartan—Nausea—Pamidronate—Paget's disease of bone	0.000917	0.000917	CcSEcCtD
Telmisartan—Vomiting—Zoledronate—Paget's disease of bone	0.000897	0.000897	CcSEcCtD
Telmisartan—Rash—Zoledronate—Paget's disease of bone	0.000889	0.000889	CcSEcCtD
Telmisartan—Dermatitis—Zoledronate—Paget's disease of bone	0.000889	0.000889	CcSEcCtD
Telmisartan—Headache—Zoledronate—Paget's disease of bone	0.000884	0.000884	CcSEcCtD
Telmisartan—Nausea—Zoledronate—Paget's disease of bone	0.000838	0.000838	CcSEcCtD
